+181.2%
MRNA vs LDOS
+27.9%
+153.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LDOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -0.4% | -3.2% | -3.5% |
| 7D | -20.0% | -4.2% | -15.7% | -18.8% |
| 30D | -1.3% | +4.1% | -5.4% | -3.3% |
| 3M | +240.0% | -9.3% | +249.3% | +251.7% |
| 6M | +339.0% | +5.8% | +333.1% | +336.8% |
| YTD | +630.0% | -27.3% | +657.2% | +691.0% |
| 1Y | +769.1% | -31.3% | +800.4% | +852.9% |
| 3Y | +181.2% | +28.5% | +152.8% | +198.2% |
| All | +181.2% | +27.9% | +153.3% | +198.2% |
Cumulative growth
Daily Returns
Daily percentage return beside LDOS.
Daily Out/Under-Performance
Portfolio return minus LDOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LDOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LDOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling